Inotiv (NOTV) Gets a Buy From Craig-Hallum
Inotiv Analyst Ratings
Inotiv Analyst Ratings
Jefferies Downgrades Inotiv to Hold From Buy, Price Target Is $3.75
Inotiv (NOTV) Receives a Buy From Craig-Hallum
Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Inotiv (NOTV)
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
Craig-Hallum Keeps Their Buy Rating on Inotiv (NOTV)
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV)
Craig-Hallum Sticks to Its Buy Rating for Inotiv (NOTV)
Jefferies Upgrades Inotiv to Buy, Cites Expanded Sales Force
Inotiv Analyst Ratings
Inotiv Upgraded to Buy With Target Raised to $11.50 From $3
Analysts' Top Healthcare Picks: Sensus Healthcare (SRTS), Inotiv (NOTV)
Lake Street Sticks to Their Buy Rating for Inotiv (NOTV)
Jefferies Adjusts Inotiv Price Target to $3 From $7.25, Maintains Hold Rating
Craig-Hallum Maintains Buy on Inotiv, Lowers Price Target to $25
Inotiv Analyst Ratings
Lake Street Remains a Buy on Inotiv (NOTV)
Lake Street Keeps Their Buy Rating on Inotiv (NOTV)